DE

Decision Diagnostics CorpOOTC DECN Stock Report

Last reporting period 31 Mar, 2021

Updated 14 Nov, 2024

Last price

Market cap $B

0.006

Micro

Exchange

OOTC - OTC

DECN Stock Analysis

DE

Uncovered

Decision Diagnostics Corp is uncovered by Eyestock quantitative analysis.

Market cap $B

0.006

Dividend yield

Shares outstanding

354.5 B

Decision Diagnostics Corp. engages in prescription and non-prescription diagnostics and home testing products. The company is headquartered in Westlake Village, California. The company went IPO on 2002-02-08. Through its subsidiary, PharmaTech Solutions, Inc., the Company provides blood glucose home testing devices like GenUltimate! and PetSure! test strips and GenUltimate!4Pets monitoring system. Its subsidiary, PharmaTech Solutions, Inc., is a manufacturer of glucose home testing products. Its electronic medical record (EMR) applications enable physicians to carry, access and update their patients’ histories, medication data and care guidelines. The company is a developer of cell phone-centric e-health products and technologies. Its technology includes MD@Hand, a wireless, personal digital assistant in the form of a smartphone application that can be downloaded and used by physicians to access and update their patient’s histories, medication data and other. The company also offers ResidenceWare, a collection of Internet-enhanced communication, integration and networking tools.

View Section: Eyestock Rating